Why have this procedure done in China specifically?

China offers advanced stem cell technology at a significantly lower cost—approximately $32,000 for the full 8-week program versus $50,000–$100,000 in the U.S. or Europe for similar protocols. Chinese hospitals have high patient volumes for intrathecal stem cell infusions, meaning experienced specialists and well-established safety protocols. Additionally, China’s regulatory framework allows for innovative cell therapies that are still in clinical trials elsewhere, providing earlier access to treatments like UC-MSC infusion combined with intensive rehab.